Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance

Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance


Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background.

Nurphoto | Nurphoto | Getty Images

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market.

Shares were down 17% at 12:30 p.m. London time, shortly after the announcement (7:30 a.m. ET).

The company said it now expects full-year sales growth of 8% to 14% at constant exchange rates, down from a prior target of 13% to 21%.

It expects annual operating profit growth of 10% to 16% versus the previously estimated target of 16% to 24%, also at constant exchange rates.

Novo Nordisk said the lower outlook was driven by weaker second-half U.S. sales growth forecasts for its Wegovy weight loss drug and Ozempic diabetes treatment.

“For Wegovy in the US, the sales outlook reflects the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition,” it added in a statement.

This is a developing story. Please check back for updates.



Source

South Korea’s Kospi hits record high as Samsung and SK Hynix soar on OpenAI partnership
World

South Korea’s Kospi hits record high as Samsung and SK Hynix soar on OpenAI partnership

The Seoul skyline. Mongkol Chuewong | Moment | Getty Images South Korea’s Kospi index jumped more than 3% Thursday to hit an all-time high, lifted by gains in heavyweight Samsung Electronics and SK Hynix. Shares in Samsung Electronics and SK Hynix, which announced a partnership with OpenAI late Wednesday to supply memory chips, rose over […]

Read More
CNBC Daily Open: Unpleasant news from the U.S. appears to be making investors cheery
World

CNBC Daily Open: Unpleasant news from the U.S. appears to be making investors cheery

Traders work at the New York Stock Exchange on Oct. 1, 2025. NYSE On Wednesday, the U.S. government ground to a halt. Stock markets, however, jumped — one benchmark even hit a record high. Traders in prediction markets are betting the shutdown will last nearly two weeks. Nothing too radical, since that’s the average length […]

Read More
SK Hynix shares hit multidecade highs, Samsung also surges as chipmakers partner with OpenAI
World

SK Hynix shares hit multidecade highs, Samsung also surges as chipmakers partner with OpenAI

Headquarters of Samsung in Mountain View, California, on October 28, 2018. Smith Collection/gado | Archive Photos | Getty Images Shares of South Korean chip heavyweights Samsung Electronics and SK Hynix surged Thursday, a day after the two companies partnered with artificial-intelligence major OpenAI as part of the U.S. firm’s Stargate initiative. Shares of Samsung hit […]

Read More